NTRK2 and early-onset autosomal dominant Alzheimer disease: Growing evidence suggest that decreases in BDNF content and defects in its signaling pathway via its receptor, TrkB, are associated with neurodegeneration and the progression of Alzheimer’s disease (MacPherson, 2017).